Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Broich

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Nature Reviews. Drug Discovery|May 23, 2024
Accelerating clinical trials in the EU (ACT EU): transforming the EU clinical trials landscapeGiacomo Capone, Björn Eriksson, Monique Al, et al.
Clinical Pharmacology and Therapeutics|November 22, 2024
Artificial Intelligence in European Medicines Regulation: From Vision to Action. Harnessing the Capabilities of Artificial Intelligence for the Benefit of Public and Animal HealthLuis Correia Pinheiro, Peter Arlett, Kit Roes, et al.
Clinical Pharmacology and Therapeutics|September 5, 2018
Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?Hans-Georg Eichler, Brigitte Bloechl-Daum, Karl Broich, et al.
Neuroscience|April 29, 2019
Ca<sub>v</sub>3.2 T-Type Calcium Channels Are Physiologically Mandatory for the Auditory SystemAndreas Lundt, Robin Seidel, Julien Soós, et al.
The European Journal of Neuroscience|October 12, 2019
Functional implications of Ca<sub>v</sub> 2.3 R-type voltage-gated calcium channels in the murine auditory system - novel vistas from brainstem-evoked response audiometryAndreas Lundt, Julien Soós, Robin Seidel, et al.
Clinical Pharmacology and Therapeutics|February 14, 2025
Clinical Evidence 2030Peter Arlett, Denise Umuhire, Patrice Verpillat, et al.
Plos One|February 7, 2024
Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer's disease miceAnna Papazoglou, Christina Henseler, Sandra Weickhardt, et al.
Neural Plasticity|April 18, 2015
Limited effects of an eIF2αS51A allele on neurological impairments in the 5xFAD mouse model of Alzheimer's diseaseKatharina Paesler, Kan Xie, Moritz M Hettich, et al.
Nature Reviews. Drug Discovery|July 2, 2010
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectivesHarald Hampel, Richard Frank, Karl Broich, et al.
Neuropharmacology|May 15, 2020
Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discoveryHarald Hampel, Andrea Vergallo, Filippo Caraci, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Nature Reviews. Drug Discovery|May 23, 2024
Accelerating clinical trials in the EU (ACT EU): transforming the EU clinical trials landscapeGiacomo Capone, Björn Eriksson, Monique Al, et al.
Clinical Pharmacology and Therapeutics|November 22, 2024
Artificial Intelligence in European Medicines Regulation: From Vision to Action. Harnessing the Capabilities of Artificial Intelligence for the Benefit of Public and Animal HealthLuis Correia Pinheiro, Peter Arlett, Kit Roes, et al.
Clinical Pharmacology and Therapeutics|September 5, 2018
Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?Hans-Georg Eichler, Brigitte Bloechl-Daum, Karl Broich, et al.
Neuroscience|April 29, 2019
Ca<sub>v</sub>3.2 T-Type Calcium Channels Are Physiologically Mandatory for the Auditory SystemAndreas Lundt, Robin Seidel, Julien Soós, et al.
The European Journal of Neuroscience|October 12, 2019
Functional implications of Ca<sub>v</sub> 2.3 R-type voltage-gated calcium channels in the murine auditory system - novel vistas from brainstem-evoked response audiometryAndreas Lundt, Julien Soós, Robin Seidel, et al.
Clinical Pharmacology and Therapeutics|February 14, 2025
Clinical Evidence 2030Peter Arlett, Denise Umuhire, Patrice Verpillat, et al.
Plos One|February 7, 2024
Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer's disease miceAnna Papazoglou, Christina Henseler, Sandra Weickhardt, et al.
Neural Plasticity|April 18, 2015
Limited effects of an eIF2αS51A allele on neurological impairments in the 5xFAD mouse model of Alzheimer's diseaseKatharina Paesler, Kan Xie, Moritz M Hettich, et al.
Nature Reviews. Drug Discovery|July 2, 2010
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectivesHarald Hampel, Richard Frank, Karl Broich, et al.
Neuropharmacology|May 15, 2020
Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discoveryHarald Hampel, Andrea Vergallo, Filippo Caraci, et al.
Pageof 10